We’re here to help you combat COVID-19 Faster
Argonaut has immediate near-term manufacturing capacity for COVID-19 vaccines, therapies, and diagnostics
Formulation
Fill
Finish
Analytical
Start your COVID-19 clinical trial sooner
Argonaut has near-term availability on our fill/finish line for COVID-19 vaccines and therapeutics. Projects can begin filling for pre-clinical through phase III trials as early as May, cutting months from the typical timeline.
Every additional vial produced means another patient protected against COVID-19. Argonaut’s state-of-the-art Bausch + Ströbel line is optimized to protect your valuable drug against loss and risk during filling.
Get your critical kit to market faster. Our team has extensive experience with PCR, NGS, and Antibody-based assay manufacturing. Formulation, filling, kitting, lyophilization, QC, and fulfillment all available under one roof.
Our team has one goal: support yours
Argonaut’s mission is to help your team succeed. Experienced project managers and manufacturing staff keep your projects on track. Our facility will continue to operate during the COVID-19 outbreak, supplying clients worldwide with life-saving technologies.
Why Outsource?
Expertise
With decades of industry experience, our team knows how to make your project successful. Take advantage of our history.
Quality
Quality is our highest priority. Let us keep up with evolving regulatory requirements, so you can focus on innovating.
Cost Savings
Pay-when-you-need-it capabilities are the economical choice. Avoid unnecessary capex and upkeep by outsourcing.
Time to Market
Accelerate your time to market by working with an established CDMO. Your drug product can be filled in months, not years.